Skip to content
OpenCapital
Get started

King Pharmaceuticals KG Other (predominantly Europe) — Gross premiums written

Other geography segments

North America
-$195K—

Similar metrics at other companies

Aflac logo
AFLOther — Gross premiums
$3.44B+4,141%
RenaissanceRe Holdings logo
RNROther — Gross premiums written (Note 7)
$73.61M+21.7%
Palomar Holdings, Inc. logo
PLMROther States — Premiums Written Gross
$282.2M+64.2%
Mercury General logo
MCYOther — Direct premiums written
$6.6M-4.3%
American Coastal Insurance Corporation logo
ACICGross premiums written (Note 5)
$149.4M-24.5%
Global Indemnity Group, LLC logo
GBLIGross premiums written (Note 5)
$96.45M-2.3%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M—
Total equity$121.4M+2,773%
Total assets$964.2M—

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-67.6%
Enterprise value$184.93M-50.0%
P/E1.2×—
P/S1.6×-24.3×

Profitability

See full
Net margin131.5%—

Returns & leverage

See full
Return on equity90.8%—
Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsWrittenGross.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's other (predominantly europe) — gross premiums written.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's other (predominantly europe) — gross premiums written?
King Pharmaceuticals (KG) reported other (predominantly europe) — gross premiums written of $1.57M in Q4 2025.
What does other (predominantly europe) — gross premiums written mean?
This metric represents the total premiums generated by insurance policies issued within the specified geographic segment before accounting for reinsurance cessions. It serves as a primary indicator of the company's top-line growth and market penetration within this region. Monitoring this figure helps investors assess the scale of underwriting activity and the company's ability to attract new business in these specific markets.